Log in | Register

A multicenter trial to compare blood culture with polymerase chain reaction in severe human sepsis

Frank Bloos| Frank Hinder| Karsten Becker| Svea Sachse| Armand Mekontso Dessap| Eberhard Straube| Vincent Cattoir| Christian Brun-Buisson| Konrad Reinhart| Georg Peters| Michael Bauer
Original
Volume 36, Issue 2 / February , 2010

Pages 241 - 247

Abstract

Objective

To assess the presence of microbial DNA in the blood by polymerase chain reaction (PCR) and its association with disease severity and markers of inflammation in severe sepsis and to compare the performance of PCR with blood culture (BC).

Design

Prospective multicentric controlled observational study.

Setting

Three surgical intensive care units in university centers and large teaching hospitals.

Patients

One hundred forty-two patients with severe sepsis and 63 surgical controls.

Interventions

Presence of microbial DNA was assessed by multiplex PCR upon enrollment, and each time a BC was obtained.

Measurements and main results

Controls had both approximately 4% positive PCRs and BCs. In severe sepsis, 34.7% of PCRs were positive compared to 16.5% of BCs (P < 0.001). Consistently, 70.3% of BCs had a corresponding PCR result, while only 21.4% of PCR results were confirmed by BC. Compared to patients with negative PCRs at enrollment, those testing positive had higher organ dysfunction scores [SOFA, median (25th–75th percentile) 12 (7–15) vs. 9 (7–11); P = 0.023] and a trend toward higher mortality (PCR negative 25.3%; PCR positive 39.1%; P = 0.115).

Conclusions

In septic patients, concordance between BC and PCR is moderate. However, PCR-based pathogen detection correlated with disease severity even if the BC remained negative, suggesting that presence of microbial DNA in the bloodstream is a significant event. The clinical utility to facilitate treatment decisions warrants investigation.

Keywords

References

  1. Martin GS, Mannino DM, Eaton S, Moss M (2003) The epidemiology of sepsis in the United States from 1979 through 2000. N Engl J Med 348:1546–1554
    • View reference on publisher's website
    • View reference on PubMed
  2. Tracey KJ, Fong Y, Hesse DG, Manogue KR, Lee AT, Kuo GC, Lowry SF, Cerami A (1987) Anti-cachectin/TNF monoclonal antibodies prevent septic shock during lethal bacteraemia. Nature 330:662–664
    • View reference on publisher's website
    • View reference on PubMed
  3. MacArthur RD, Miller M, Albertson T, Panacek E, Johnson D, Teoh L, Barchuk W (2004) Adequacy of early empiric antibiotic treatment and survival in severe sepsis: experience from the MONARCS trial. Clin Infect Dis 38:284–288
    • View reference on publisher's website
    • View reference on PubMed
  4. Micek ST, Isakow W, Shannon W, Kollef MH (2005) Predictors of hospital mortality for patients with severe sepsis treated with Drotrecogin alfa (activated). Pharmacotherapy 25:26–34
    • View reference on publisher's website
    • View reference on PubMed
  5. Ibrahim EH, Sherman G, Ward S, Fraser VJ, Kollef MH (2000) The influence of inadequate antimicrobial treatment of bloodstream infections on patient outcomes in the ICU setting. Chest 118:146–155
    • View reference on publisher's website
    • View reference on PubMed
  6. Kumar A, Roberts D, Wood KE, Light B, Parrillo JE, Sharma S, Suppes R, Feinstein D, Zanotti S, Taiberg L, Gurka D, Cheang M (2006) Duration of hypotension before initiation of effective antimicrobial therapy is the critical determinant of survival in human septic shock. Crit Care Med 34:1589–1596
    • View reference on publisher's website
    • View reference on PubMed
  7. Dellinger RP, Levy MM, Carlet JM, Bion J, Parker MM, Jaeschke R, Reinhart K, Angus DC, Brun-Buisson C, Beale R, Calandra T, Dhainaut JF, Gerlach H, Harvey M, Marini JJ, Marshall J, Ranieri M, Ramsay G, Sevransky J, Thompson BT, Townsend S, Vender JS, Zimmerman JL, Vincent JL (2008) Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock: 2008. Intensive Care Med 34:17–60
  8. Lehmann LE, Hunfeld KP, Emrich T, Haberhausen G, Wissing H, Hoeft A, Stuber F (2007) A multiplex real-time PCR assay for rapid detection and differentiation of 25 bacterial and fungal pathogens from whole blood samples. Med Microbiol Immunol 197(3):313–324
    • View reference on publisher's website
    • View reference on PubMed
  9. Louie RF, Tang Z, Albertson TE, Cohen S, Tran NK, Kost GJ (2008) Multiplex polymerase chain reaction detection enhancement of bacteremia and fungemia. Crit Care Med 36:1487–1492
    • View reference on publisher's website
    • View reference on PubMed
  10. Westh H, Lisby G, Breysse F, Boddinghaus B, Chomarat M, Gant V, Goglio A, Raglio A, Schuster H, Stuber F, Wissing H, Hoeft A (2009) Multiplex real-time PCR and blood culture for identification of bloodstream pathogens in patients with suspected sepsis. Clin Microbiol Infect. doi:10.1111/j.1469-0691.2009.02736.x
  11. ACCP/SCCM Consensus Conference Committee (1992) Definition for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. Crit Care Med 20:864–874
  12. Calandra T, Cohen J (2005) The international sepsis forum consensus conference on definitions of infection in the intensive care unit. Crit Care Med 33:1538–1548
    • View reference on publisher's website
    • View reference on PubMed
  13. Landis JR, Koch GG (1977) The measurement of observer agreement for categorical data. Biometrics 33:159–174
    • View reference on publisher's website
    • View reference on PubMed
  14. Development Core Team R (2008) R: A language and environment for statistical computing. R Foundation for Statistical Computing, Vienna
  15. van Loon HJ, Vriens MR, Fluit AC, Troelstra A, van der Werken C, Verhoef J, Bonten MJ (2005) Antibiotic rotation and development of gram-negative antibiotic resistance. Am J Respir Crit Care Med 171:480–487
    • View reference on publisher's website
    • View reference on PubMed
  16. Adams DH, Eksteen B, Curbishley SM (2008) Immunology of the gut and liver: a love/hate relationship. Gut 57:838–848
    • View reference on publisher's website
    • View reference on PubMed
  17. Wellinghausen N, Wirths B, Franz AR, Karolyi L, Marre R, Reischl U (2004) Algorithm for the identification of bacterial pathogens in positive blood cultures by real-time LightCycler polymerase chain reaction (PCR) with sequence-specific probes. Diagn Microbiol Infect Dis 48:229–241
    • View reference on publisher's website
    • View reference on PubMed
  18. Hadgu A, Dendukuri N, Hilden J (2005) Evaluation of nucleic acid amplification tests in the absence of a perfect gold-standard test: a review of the statistical and epidemiologic issues. Epidemiology 16:604–612
    • View reference on publisher's website
    • View reference on PubMed
  19. Rangel-Frausto MS, Pittet D, Costigan M, Hwang T, Davis CS, Wenzel RP (1995) The natural history of the systemic inflammatory response syndrome (SIRS). A prospective study. JAMA 273:117–123
    • View reference on publisher's website
    • View reference on PubMed
  20. Bauer S, Kirschning CJ, Hacker H, Redecke V, Hausmann S, Akira S, Wagner H, Lipford GB (2001) Human TLR9 confers responsiveness to bacterial DNA via species-specific CpG motif recognition. Proc Natl Acad Sci USA 98:9237–9242
    • View reference on publisher's website
    • View reference on PubMed
  21. Petti CA (2007) Detection and identification of microorganisms by gene amplification and sequencing. Clin Infect Dis 44:1108–1114
    • View reference on publisher's website
    • View reference on PubMed
  22. Blumberg HM, Jarvis WR, Soucie JM, Edwards JE, Patterson JE, Pfaller MA, Rangel-Frausto MS, Rinaldi MG, Saiman L, Wiblin RT, Wenzel RP (2001) Risk factors for candidal bloodstream infections in surgical intensive care unit patients: the NEMIS prospective multicenter study. The National Epidemiology of Mycosis Survey. Clin Infect Dis 33:177–186
    • View reference on publisher's website
    • View reference on PubMed

Sign In

Connect with ICM

Top 5 Articles Editors Picks Supplement